These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24391098)

  • 1. Visualization of O-GlcNAc glycosylation stoichiometry and dynamics using resolvable poly(ethylene glycol) mass tags.
    Clark PM; Rexach JE; Hsieh-Wilson LC
    Curr Protoc Chem Biol; 2013; 5(4):281-302. PubMed ID: 24391098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
    Thompson JW; Griffin ME; Hsieh-Wilson LC
    Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.
    Rexach JE; Rogers CJ; Yu SH; Tao J; Sun YE; Hsieh-Wilson LC
    Nat Chem Biol; 2010 Sep; 6(9):645-51. PubMed ID: 20657584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of Chemoenzymatic Mass Tagging by Strain-Promoted Cycloaddition (SPAAC) for the Determination of O-GlcNAc Stoichiometry by Western Blotting.
    Darabedian N; Thompson JW; Chuh KN; Hsieh-Wilson LC; Pratt MR
    Biochemistry; 2018 Oct; 57(40):5769-5774. PubMed ID: 30169966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics.
    Khidekel N; Ficarro SB; Clark PM; Bryan MC; Swaney DL; Rexach JE; Sun YE; Coon JJ; Peters EC; Hsieh-Wilson LC
    Nat Chem Biol; 2007 Jun; 3(6):339-48. PubMed ID: 17496889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct in-gel fluorescence detection and cellular imaging of O-GlcNAc-modified proteins.
    Clark PM; Dweck JF; Mason DE; Hart CR; Buck SB; Peters EC; Agnew BJ; Hsieh-Wilson LC
    J Am Chem Soc; 2008 Sep; 130(35):11576-7. PubMed ID: 18683930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of O-GlcNAc sites on proteins.
    Whelan SA; Hart GW
    Methods Enzymol; 2006; 415():113-33. PubMed ID: 17116471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Monitoring of Protein O-GlcNAcylation by High-Resolution Native Mass Spectrometry.
    Leney AC; Rafie K; van Aalten DMF; Heck AJR
    ACS Chem Biol; 2017 Aug; 12(8):2078-2084. PubMed ID: 28609614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of the nuclear pore.
    Li B; Kohler JJ
    Traffic; 2014 Apr; 15(4):347-61. PubMed ID: 24423194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and analysis of (O-linked beta-N-acetylglucosamine)-modified proteins.
    Zachara NE
    Methods Mol Biol; 2009; 464():227-54. PubMed ID: 18951188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosolic O-glycosylation is abundant in nerve terminals.
    Cole RN; Hart GW
    J Neurochem; 2001 Dec; 79(5):1080-9. PubMed ID: 11739622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic Chemical Reporter of O-GlcNAc Modifications, Highlighting the Notable Substrate Flexibility of O-GlcNAc Transferase.
    Jackson EG; Cutolo G; Yang B; Yarravarapu N; Burns MWN; Bineva-Todd G; Roustan C; Thoden JB; Lin-Jones HM; van Kuppevelt TH; Holden HM; Schumann B; Kohler JJ; Woo CM; Pratt MR
    ACS Chem Biol; 2022 Jan; 17(1):159-170. PubMed ID: 34931806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc Site Mapping by Using a Combination of Chemoenzymatic Labeling, Copper-Free Click Chemistry, Reductive Cleavage, and Electron-Transfer Dissociation Mass Spectrometry.
    Ma J; Wang WH; Li Z; Shabanowitz J; Hunt DF; Hart GW
    Anal Chem; 2019 Feb; 91(4):2620-2625. PubMed ID: 30657688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleocytoplasmic glycosylation, O-GlcNAc: identification and site mapping.
    Zachara NE; Cheung WD; Hart GW
    Methods Mol Biol; 2004; 284():175-94. PubMed ID: 15173616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-GlcNAc-specific antibody CTD110.6 cross-reacts with N-GlcNAc2-modified proteins induced under glucose deprivation.
    Isono T
    PLoS One; 2011 Apr; 6(4):e18959. PubMed ID: 21526146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates.
    Shen DL; Gloster TM; Yuzwa SA; Vocadlo DJ
    J Biol Chem; 2012 May; 287(19):15395-408. PubMed ID: 22311971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-N-Acetylglucosamine (O-GlcNAc) is a novel regulator of mitosis-specific phosphorylations on histone H3.
    Fong JJ; Nguyen BL; Bridger R; Medrano EE; Wells L; Pan S; Sifers RN
    J Biol Chem; 2012 Apr; 287(15):12195-203. PubMed ID: 22371497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.
    Vosseller K; Wells L; Lane MD; Hart GW
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5313-8. PubMed ID: 11959983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.
    Khidekel N; Ficarro SB; Peters EC; Hsieh-Wilson LC
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13132-7. PubMed ID: 15340146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.